Clinical trials
Every registered trial of Cerebrolysin
53 studies, 7 still enrolling.
Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Cerebrolysin has a real but limited body of human research.
- 53 registered studies in total.
- 7 are still enrolling people, so this is active research, not just history.
What kind of research
- 49 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 6,394 people took part in those.
- A further 4 studies only looked at records of people already taking it. These are counted separately because nobody was given the peptide for the study, so they cannot prove cause and effect.
How far along it is
- 21 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
- 11 have published results in the medical literature that anyone can read.
- The research spans 19 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.
Filter
Showing 53 of 53 trials for Cerebrolysin.
Cerebrolysin After Reperfusion in Extended-window EndoVascular Thrombectomy
Chang Gung Memorial Hospital
Acute Ischemic Stroke
FSNANO28012025
Foundation For The Study Of Nanoneuroscience And Neuroregeneration
Stroke
Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial
Cardinal Stefan Wyszynski University
Intracerebral Hemorrhage · Hemorrhagic Stroke, Intracerebral · Hemorrhagic Stroke · Stroke
Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study
University Medical Centre Ljubljana
Ischemic Stroke, Acute · Rehabilitation Outcome · Cerebrolysin
Effects of Cerebrolysin on Language Ability in Non-fluent Aphasia Patients After Stroke: A Randomized, Placebo-controlled, Double-blinded, Single Center Study
Yonsei University
Stroke
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
C-RETURN
Foundation For The Study Of Nanoneuroscience And Neuroregeneration
Traumatic brain injury
Cerebrolysin as an Add-On Therapy to Standard Treatment of Basilar Artery Occlusion
University Hospital Sestre Milosrdnice
Basilar Artery Occlusion · Posterior Circulation Brain Infarction
Add-on benefit of cerebrolysin to acute stroke patients given recombinant tissue plasminogen activator
Baguio General Hospital and Medical Center
Acute ischemic stroke after intravenous thrombolysis
Triple therapy to boost stroke recovery in Azerbaijan: combining brain stimulation, medication, and physiotherapy
Azerbaijan Medical University
To study the effectiveness of the use of cerebrolysin in combination with physical methods of treatment (direct current stimulation, kinesitherapy, massage) in the rehabilitation of patients with cerebral stroke.
Cerebrolysin in Critically Ill Patients With Delirium
Medical University of Lublin
Cognitive Impairment
CERebrolysin In CADASIL
Ever Neuro Pharma GmbH
Cadasil
CERICA - CERebrolysin In CADASIL - A randomized, double-blind, single-centre, two-period cross-over, placebo-controlled trial on safety and efficacy in patients with genetically proven CADASIL
Ever Neuro Pharma GmbH
Cerebral Autosomal Dominant Arteriopathy with subcortical Infarcts and Leukoencephalopathy (CADASIL)
A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Stroke Patients Undergoing EndoVascular Treatment (EVT)
Shaare Zedek Medical Center
Acute Ischemic Stroke
Combined Cerebrolysin and Amantadine Sulfate Administration for Patients With Traumatic Brain Injury in the ICU
Ain Shams University
Traumatic Brain Injury
Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
October 6 University
Bell Palsy
Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness
Konkuk University Medical Center
Disorder of Consciousness · Hemorrhagic Stroke
Cerebrolysin in Prevention of Postoperative Delirium in Cardiac Surgery
Medical University of Lublin
Neurocognitive Disorders · Surgery-Complications · Critical Illness · Brain Damage
CERebrolysine Effect on Blood-brain Barrier in acUte Ischemic Stroke
Poznan University of Medical Sciences
Acute Ischemic Stroke
Effect of Cerebrolysin on the Blood Brain Barrier in Patients With Diabetes and Ischemic Stroke
Hospital Universitario Dr. Jose E. Gonzalez
Ischemic Stroke, Acute · Diabetes Mellitus, Type 2 · Blood Brain Barrier
Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants
Sherifa Ahmed Hamed
Post-covid-19 Persistent Smell and Taste Disorders
Clinical study to assess treatment effects of Cerebrolysin in amyotrophic lateral sclerosis
Instituto Cardiológico Banfield
Amyotrophic lateral sclerosis
IMPULSE - StIMulation of Brain Plasticity to Improve Upper Limb Recovery After StrokE
Ever Neuro Pharma GmbH
Chronic Stroke · Subacute Stroke
Effects of Cerebrolysin on Level of Consciousness and Brain Metabolism in Disorder of Consciousness After Stroke: Single Center Randomized Controlled Study
Yonsei University
Stroke
Early Administration of Cerebrolysin on the Outcome of Patients With Acute Stroke Undergoing EVT
Pomeranian Medical University Szczecin
Stroke, Acute, Ischemic
Cerebrolysin in SAH (Subarachnoidal Haemorrhage) - Observational Study
Pomeranian Medical University Szczecin
SAH (Subarachnoid Hemorrhage)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Efficacy of Cerebrolysin Treatment as an add-on Therapy to Mechanical Thrombectomy in Acute Ischemic Stroke.
Military Institute od Medicine National Research Institute
Stroke, Ischemic · Stroke, Acute · Stroke Sequelae
Cerebrolycin for Treatment of Covid-related Anosmia and Ageusia
Assiut University
Covid19 Related Anosmia and Aguesia
Can treatment with Cerebrolysin improve recovery after acute ischemic stroke?
The foundation for the study of neuroscience and neuroregeneration
Radiologically confirmed acute ischemic stroke with onset within 72 hours prior to screening
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Can Cerebrolysin improve aphasia after ischemic stroke?
The foundation for the study of neuroscience and neuroregeneration (SSNN)
Patients with Broca or mixed non-fluent aphasia post ischemic stroke with onset 3-5 days prior to inclusion
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Evaluation of the Effect of Neuroprotective Drug on Treatment Result in Patients After Traumatic Brain Injury
Pomeranian Medical University Szczecin
TBI (Traumatic Brain Injury)
Can adding cerebrolysin early to clot-dissolving stroke treatment reduce the risk of brain bleeding?
State Autonomous Institution of Health Interregional Clinical Diagnostic Center
Ischemic stroke
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Cerebrolysin REGistry Study in Stroke - a High-quality Observational Study of Comparative Effectiveness
Ever Neuro Pharma GmbH
Acute Ischemic Stroke
Can treatment with Cerebrolysin and magnetic stimulation of the brain improve recovery after traumatic brain injury?
EN: The foundation for the study of neuroscience and neuroregeneration (RO: Fundatia pentru Studiul Nanoneurostiintelor si Neuroregenerarii)
Traumatic Brain Injury (TBI) onset 30 days prior to screening
Evaluation of efficacy and safety of Cerebrolysin as add-on therapy in patients with acute stroke after failed recanalisation therapy
University Hospital Centre Zagreb
Acute ischemic stroke
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome
Mansoura University Children Hospital
Down Syndrome
Cerebrolysin and Neurodevelopment in Preterm Infants
Mansoura University Children Hospital
Infant Development · Cerebral Palsy · Preterm Infant
Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke
Samsung Medical Center
Stroke
Comprehensive Reparative Therapy in Ischemic Stroke COMplex Repair in Ischemic Stroke-Arm
Clinical Institute of the Brain, Russia
Ischemic Stroke
Hair Repigmentation During Cerebrolysin Therapy
Universidad Autonoma de Nuevo Leon
Hair Problems
Cerebrolysin REGistry Study in Stroke
Ever Neuro Pharma GmbH
Ischemic Stroke
Cerebrolysin Neural Repair Therapy in Children With Traumatic Brain Injury and Cerebral Palsy
Ain Shams University
Cerebral Palsy Children · Children With Traumatic Brain Injury · Mental Handicap · Delayed Speech Development
Randomized, Double-blind, Placebo-controlled Trial to Investigate Safety and Efficacy of Cerebrolysin™ in Patients With Aneurysmal Subarachnoid Hemorrhage
Kwong Wah Hospital
Subarachnoid Hemorrhage · Intracranial Aneurysm · Delayed Cerebral Ischemia · Delayed Ischemic Neurological Deficit
The CAPTAIN Trial: Cerebrolysin Asian Pacific Trial in Acute Brain Injury and Neurorecovery
Ever Neuro Pharma GmbH
Traumatic Brain Injury
Can Cerebrolysin improve recovery after traumatic brain injury?
EN: The foundation for the study of neuroscience and reuroregeneration (RO: Fundatia pentru Studiul Nanoneurostiintelor si Neuroregenerarii)
Traumatic brain injury (TBI) with Glasgow Coma Scale (GCS) scores between 7 and 12.
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Study of Cerebrolysin for Treatment of Infants With History of Neonatal Hypoxic Ischemic Encephalopathy
Sahar M.A. Hassanein, MD
Hypoxic-Ischemic Encephalopathy
Effects of Cerebrolysin on Motor Recovery in Patients With Subacute Stroke
Samsung Medical Center
Cerebrolysin
Navigation Brain Stimulation for Evaluation of the Neuroprotective Drug Efficiency in Patients After Ischemic Stroke.
Clinical Institute of the Brain, Russia
Stroke
Dl-3-n-butylphthalide and Cerebrolysin Treatment in Acute Ischemic Stroke
Shanghai 6th People's Hospital
Acute Cerebral Stroke Within 12 Hours for the First Time
A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia
Ever Neuro Pharma GmbH
Vascular Dementia
The Safety and Efficacy of Cerebrolysin in Patients With Acute Ischemic Stroke
Ever Neuro Pharma GmbH
Ischemic Stroke
Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke
Ever Neuro Pharma GmbH
Stroke
Comparative Study to Test Safety and Efficacy of Neurotrophic and Cholinergic Treatment of Alzheimer's Disease
Ever Neuro Pharma GmbH
Alzheimer Disease
Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
Ever Neuro Pharma GmbH
Alzheimer Disease
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Cerebrolysin is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.